http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 18 Jun 2026 17:43:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Tomasello+Shawn/26667458.html si-local-file:///var/storage/secattach/20260618/26667458.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Tomasello+Shawn/26667458.html Thu, 18 Jun 2026 17:43:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Tomasello+Shawn/26667458.html si-local-file:///var/storage/secattach/20260618/26667458.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Tomasello+Shawn/26667458.html Thu, 18 Jun 2026 17:43:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+THEUER+CHARLES/26667453.html si-local-file:///var/storage/secattach/20260618/26667453.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+THEUER+CHARLES/26667453.html Thu, 18 Jun 2026 17:41:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+THEUER+CHARLES/26667453.html si-local-file:///var/storage/secattach/20260618/26667453.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+THEUER+CHARLES/26667453.html Thu, 18 Jun 2026 17:41:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Miller-Rich+Nancy/26667451.html si-local-file:///var/storage/secattach/20260618/26667451.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Miller-Rich+Nancy/26667451.html Thu, 18 Jun 2026 17:40:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Miller-Rich+Nancy/26667451.html si-local-file:///var/storage/secattach/20260618/26667451.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Miller-Rich+Nancy/26667451.html Thu, 18 Jun 2026 17:40:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+GRAY+SUSANNAH/26667444.html si-local-file:///var/storage/secattach/20260618/26667444.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+GRAY+SUSANNAH/26667444.html Thu, 18 Jun 2026 17:39:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+GRAY+SUSANNAH/26667444.html si-local-file:///var/storage/secattach/20260618/26667444.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+GRAY+SUSANNAH/26667444.html Thu, 18 Jun 2026 17:39:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+MILLIGAN+JOHN+F/26667424.html si-local-file:///var/storage/secattach/20260618/26667424.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+MILLIGAN+JOHN+F/26667424.html Thu, 18 Jun 2026 17:33:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+MILLIGAN+JOHN+F/26667424.html si-local-file:///var/storage/secattach/20260618/26667424.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+MILLIGAN+JOHN+F/26667424.html Thu, 18 Jun 2026 17:33:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+SBLENDORIO+GLENN/26667414.html si-local-file:///var/storage/secattach/20260618/26667414.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+SBLENDORIO+GLENN/26667414.html Thu, 18 Jun 2026 17:30:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+SBLENDORIO+GLENN/26667414.html si-local-file:///var/storage/secattach/20260618/26667414.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+SBLENDORIO+GLENN/26667414.html Thu, 18 Jun 2026 17:30:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Chacko+Jacob/26667396.html si-local-file:///var/storage/secattach/20260618/26667396.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Chacko+Jacob/26667396.html Thu, 18 Jun 2026 17:29:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Chacko+Jacob/26667396.html si-local-file:///var/storage/secattach/20260618/26667396.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+17++Filed+by%3A+Chacko+Jacob/26667396.html Thu, 18 Jun 2026 17:29:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+01++Filed+by%3A+Kirn+David/26592664.html si-local-file:///var/storage/secattach/20260602/26592664.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+01++Filed+by%3A+Kirn+David/26592664.html Tue, 02 Jun 2026 16:49:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+01++Filed+by%3A+Kirn+David/26592664.html si-local-file:///var/storage/secattach/20260602/26592664.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++4D+Molecular+Therapeutic++For%3A+Jun+01++Filed+by%3A+Kirn+David/26592664.html Tue, 02 Jun 2026 16:49:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++144++++++++4D+Molecular+Therapeutic+++++++++++++++Filed+by%3A+Kirn+David/26585292.html si-local-file:///var/storage/secattach/20260601/26585292.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++4D+Molecular+Therapeutic+++++++++++++++Filed+by%3A+Kirn+David/26585292.html Mon, 01 Jun 2026 17:40:00 -0400 FDMT O.47011821 http://www.streetinsider.com/SEC+Filings/Form++144++++++++4D+Molecular+Therapeutic+++++++++++++++Filed+by%3A+Kirn+David/26585292.html si-local-file:///var/storage/secattach/20260601/26585292.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++4D+Molecular+Therapeutic+++++++++++++++Filed+by%3A+Kirn+David/26585292.html Mon, 01 Jun 2026 17:40:00 -0400 FDMT O.47011821 http://www.streetinsider.com/Press+Releases/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html <p>EMERYVILLE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in June.</p> <p><strong>Jefferies Global Healthcare Conference</strong><br/></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:30%; width:30%; min-width:30%;;vertical-align: top ; ">Presentation Date:</td><td style="max-width:70%; width:70%; min-width:70%;;vertical-align: top ; ">Wednesday, June 3, 2026</td></tr><tr><td style="vertical-align: top ; ">Presentation Time:</td><td style="vertical-align: top ; ">3:10 p.m. ET</td></tr></table> <p><strong><br/>Goldman Sachs 47</strong><strong>th</strong><strong> Annual http://www.streetinsider.com/Press+Releases/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html Wed, 27 May 2026 08:00:00 -0400 A.06822034 FDMT O.20026344 O.47011821 http://www.streetinsider.com/Press+Releases/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html <p>EMERYVILLE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in June.</p> <p><strong>Jefferies Global Healthcare Conference</strong><br/></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:30%; width:30%; min-width:30%;;vertical-align: top ; ">Presentation Date:</td><td style="max-width:70%; width:70%; min-width:70%;;vertical-align: top ; ">Wednesday, June 3, 2026</td></tr><tr><td style="vertical-align: top ; ">Presentation Time:</td><td style="vertical-align: top ; ">3:10 p.m. ET</td></tr></table> <p><strong><br/>Goldman Sachs 47</strong><strong>th</strong><strong> Annual http://www.streetinsider.com/Press+Releases/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html Wed, 27 May 2026 08:00:00 -0400 A.06822034 FDMT O.20026344 O.47011821 http://www.streetinsider.com/Press+Releases/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html <p>EMERYVILLE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in June.</p> <p><strong>Jefferies Global Healthcare Conference</strong><br/></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:30%; width:30%; min-width:30%;;vertical-align: top ; ">Presentation Date:</td><td style="max-width:70%; width:70%; min-width:70%;;vertical-align: top ; ">Wednesday, June 3, 2026</td></tr><tr><td style="vertical-align: top ; ">Presentation Time:</td><td style="vertical-align: top ; ">3:10 p.m. ET</td></tr></table> <p><strong><br/>Goldman Sachs 47</strong><strong>th</strong><strong> Annual http://www.streetinsider.com/Press+Releases/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html Wed, 27 May 2026 08:00:00 -0400 A.06822034 FDMT O.20026344 O.47011821 http://www.streetinsider.com/Press+Releases/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html <p>EMERYVILLE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in June.</p> <p><strong>Jefferies Global Healthcare Conference</strong><br/></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:30%; width:30%; min-width:30%;;vertical-align: top ; ">Presentation Date:</td><td style="max-width:70%; width:70%; min-width:70%;;vertical-align: top ; ">Wednesday, June 3, 2026</td></tr><tr><td style="vertical-align: top ; ">Presentation Time:</td><td style="vertical-align: top ; ">3:10 p.m. ET</td></tr></table> <p><strong><br/>Goldman Sachs 47</strong><strong>th</strong><strong> Annual http://www.streetinsider.com/Press+Releases/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html Wed, 27 May 2026 08:00:00 -0400 A.06822034 FDMT O.20026344 O.47011821 http://www.streetinsider.com/Globe+Newswire/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html <p>EMERYVILLE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in June.</p> <p><strong>Jefferies Global Healthcare Conference</strong><br/></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:30%; width:30%; min-width:30%;;vertical-align: top ; ">Presentation Date:</td><td style="max-width:70%; width:70%; min-width:70%;;vertical-align: top ; ">Wednesday, June 3, 2026</td></tr><tr><td style="vertical-align: top ; ">Presentation Time:</td><td style="vertical-align: top ; ">3:10 p.m. ET</td></tr></table> <p><strong><br/>Goldman Sachs 47</strong><strong>th</strong><strong> Annual http://www.streetinsider.com/Globe+Newswire/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html Wed, 27 May 2026 08:00:00 -0400 A.06822034 FDMT O.20026344 O.47011821 http://www.streetinsider.com/Globe+Newswire/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html <p>EMERYVILLE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in June.</p> <p><strong>Jefferies Global Healthcare Conference</strong><br/></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:30%; width:30%; min-width:30%;;vertical-align: top ; ">Presentation Date:</td><td style="max-width:70%; width:70%; min-width:70%;;vertical-align: top ; ">Wednesday, June 3, 2026</td></tr><tr><td style="vertical-align: top ; ">Presentation Time:</td><td style="vertical-align: top ; ">3:10 p.m. ET</td></tr></table> <p><strong><br/>Goldman Sachs 47</strong><strong>th</strong><strong> Annual http://www.streetinsider.com/Globe+Newswire/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html Wed, 27 May 2026 08:00:00 -0400 A.06822034 FDMT O.20026344 O.47011821 http://www.streetinsider.com/Globe+Newswire/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html <p>EMERYVILLE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in June.</p> <p><strong>Jefferies Global Healthcare Conference</strong><br/></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:30%; width:30%; min-width:30%;;vertical-align: top ; ">Presentation Date:</td><td style="max-width:70%; width:70%; min-width:70%;;vertical-align: top ; ">Wednesday, June 3, 2026</td></tr><tr><td style="vertical-align: top ; ">Presentation Time:</td><td style="vertical-align: top ; ">3:10 p.m. ET</td></tr></table> <p><strong><br/>Goldman Sachs 47</strong><strong>th</strong><strong> Annual http://www.streetinsider.com/Globe+Newswire/4DMT+to+Participate+in+Upcoming+Investor+Conferences/26553690.html Wed, 27 May 2026 08:00:00 -0400 A.06822034 FDMT O.20026344 O.47011821